Media
News and press releases
Welcome to our media section. Check out the latest news and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information.
Latest pressreleases
Latest News
Cinclus Pharma at Redeye Investor Forum in Gothenburg
Cinclus Pharma participates at Redeye Investor Forum in Gothenburg October 10th. Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of linaprazan glurate.
Cinclus Pharma's CEO Christer Ahlberg interviewed by Redeye
Cinclus Pharma's CEO Christer Ahlberg was interviewed by Okee Williams at Redeye AB on September 23, about the company and the development of the drug candidate linaprazan glurate.
Watch the presentation from Redeye Investor Forum Online September 19th
Christer Ahlberg, CEO of Cinclus Pharma, was invited to present the company's latest updates and the development of linaprazan glurate at the Redeye Investor Forum Online on September 19th, 2024.
Cinclus Pharma at Redeye Investor Forum Online, September 19th
Christer Ahlberg, CEO of Cinclus Pharma, will present the company's latest updates and the development of linaprazan glurate at Redeye Investor Forum Online on September 19th.
Cinclus Pharma in media
Cinclus Pharma's CEO Christer Ahlberg interviewed by Redeye
2024-09-23Cinclus Pharma's CEO Christer Ahlberg was interviewed by Okee Williams at Redeye AB on September 23, about the company and the development of the drug candidate linaprazan glurate.
Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Börspodden
2024-06-26Christer Ahlberg, participated in Börspodden to talk about the listing and the upcoming plans for the company. Listen to the interview at 00:43:25 (in Swedish).
Christer Ahlberg, CEO of Cinclus Pharma participates in EFN Börslunch
2024-06-19[Swedish link] CEO of Cinclus Pharma, Christer Ahlberg, in EFN Börslunch at 10:45 June 19th.
Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Trading Direkt
2024-06-18[Swedish link] Trading Direkt 2024-06-18 | IPO Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma, in an interview with Nordnet
2024-06-14Christer Ahlberg, CEO of Cinclus Pharma, talks about the company and the drug candidate linaprazan glurate in an interview with Nordnet.